| | Closure of Trading Window | 29/12/23 14:35 | Insider Trading / SAST |  |
| | The Trading Window for dealing in the Securities of the Company will be closed with effect from Monday, January 1, 2024 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Nine Months'' period ending December 31, 2023. | |
| |
| | Disclosure Of The Details Of The Order Dated 3Rd October, 2023, Received From The Office Of The Commissioner Of Central Goods & Service Tax And Central Excise, Raigad. | 08/12/23 18:43 | Company Update | |
| | Further to the intimation dated 7th December, 2023, please find enclosed the details of the order dated 3rd October, 2023, received on 6th December, 2023 from the office of the Commissioner of Central Goods & Service Tax and Central Excise, Raigad | |
| |
| | Intimation Of Receipt Of An Order Dated 3Rd October, 2023, From The Office Of The Commissioner Of Central Goods & Service Tax And Central Excise, Raigad. | 07/12/23 17:19 | Company Update | |
| | This is to inform you under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that Astec LifeSciences Limited ("Company" / "Astec") has, on 6th December, 2023, received an order dated 3rd October 2023, from the Commissioner of Central Goods and Service Tax and Excise, Raigad, confirming levy of Central Excise Duty of Rs. 0.64 Crore, payable along with interest thereon .... | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 28/10/23 17:52 | Company Update | |
| | kindly find enclosed the copies of the newspaper publications of the unaudited financial results for the quarter and Half Year ended September 30, 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Press Release / Media Release | 27/10/23 18:35 | Company Update | |
| | Please find enclosed Media Release for the Quarter and Half Year ended September 30, 2023 | |
| |
| | Outcome Of Board Meeting Held On October 27, 2023 | 27/10/23 17:05 | Result | |
| | Please find enclosed outcome of Board Meeting held on October 27, 2023 | |
| |
| | Board Meeting Outcome for Outcome Of Board Meeting Held On October 27, 2023 | 27/10/23 17:03 | Board Meeting | |
| | Kindly find enclosed Outcome of Board Meeting held on October 27, 2023 | |
| |
| | Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | 10/10/23 17:03 | Board Meeting | |
| | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled to be held on Friday, .... | |
| |
| | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 06/10/23 16:17 | Company Update | |
| | Kindly find enclosed the compliance certificate received from Registrar and Share Transfer Agent (RTA) of Astec LifeSciences Limited for the Quarter ended September 30, 2023. | |
| |
| | Closure of Trading Window | 29/09/23 18:59 | Insider Trading / SAST | |
| | Kindly find enclosed the intimation of the Trading Window Closure for the Quarter and Half Year ended September 30, 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | 29/08/23 17:43 | Company Update | |
| | Intimation under Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations, 2015 pertaining to ESOP 2012 | |
| |
| | Announcement under Regulation 30 (LODR)-Allotment | 22/08/23 22:35 | Company Update | |
| | Allotment of 4,900 (Four Thousand and Nine Hundred) Rated, Listed, Unsecured, Redeemable, Taxable, Non-Convertible Debentures of Nominal value of Rs.1,00,000/-(Rupees One Lakh Only) each, aggregating to Rs.49,00,00,000/-(Rupees Forty Nine Crore Only) on private placement basis by Astec LifeSciences Limited. | |
| |
| | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | 09/08/23 16:44 | Company Update | |
| | This is to inform you that the Nomination and Remuneration Committee of Board of Directors of the Company has approved the allotment of 2,000 Equity Shares of Face Value of Rs.10 each, upon exercise of Options granted under Employee Stock Option Scheme 2015 ("ESOS 2015") at an exercise price of Rs.387.35 per Option. | |
| |
| | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | 02/08/23 10:48 | Insider Trading / SAST | |
| | The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund | |
| |
| | Voting Results Of The 29Th Annual General Meeting Held On July 27, 2023 Pursuant To Regulation 44(3) | 28/07/23 18:10 | AGM/EGM | |
| | Please find enclosed the Results of voting pursuant to Regulation 44(3) of SEBI Listing Regulation, 2015. | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 28/07/23 15:59 | Company Update | |
| | Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the SEBI Listing Regulations, 2015, please find attached the enclosed copies of the newspaper publications for the Unaudited Financial Results for the Quarter ended June 30, 2023. | |
| |
| | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | 28/07/23 15:32 | AGM/EGM | |
| | Please find attached the proceedings of the 29th Annual General Meeting ("29th AGM") along with the copy of the Scrutinizer''s Report and the Annual Report adopted by the Shareholders of the Company. | |
| |
| | Shareholder Meeting / Postal Ballot-Outcome of AGM | 28/07/23 15:25 | AGM/EGM | |
| | Please find attached outcome of 29th Annual General Meeting ("29th AGM") held on Thursday, 27th July, 2023 along with the copy of the Scrutinizer''s Report and Annual Report adopted by the Shareholders of the Company. | |
| |
| | Announcement under Regulation 30 (LODR)-Press Release / Media Release | 27/07/23 15:51 | Company Update | |
| | We have enclosed the copy of the Press Release / Media Release and the same is being placed on the website of the Company. | |
| |
| | Board Meeting Outcome for Outcome Of Board Meeting Held On July 27, 2023 | 27/07/23 15:19 | Board Meeting | |
| | Kindy find enclosed the Outcome of the Board Meeting held by the Astec LifeSciences Limited on July 27, 2023. | |
| |
| | Outcome Of The Board Meeting Held On 27Th July, 2023 | 27/07/23 15:18 | Result | |
| | Pursuant to Regulation 30, 33 and 52(4) of the SEBI Listing Regulations, this is to inform you that the Board of Directors of Company at its Meeting held today, i.e. July 27, 2023 has approved the Unaudited Financial Results along with the noting of the Limited Review Report of the Statutory Auditor. | |
| |
| | Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | 20/07/23 20:37 | Board Meeting | |
| | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled .... | |
| |
| | Intimation / Disclosure Of Event Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') About The Communication To The Shareholders Regarding Income Tax Rules With Respect To Tax Deduction At Source On Dividend For The Financial Year 2022-23, If Declared | 19/07/23 19:06 | Company Update | |
| | We wish to inform you that an email communication has been sent to the Shareholders having their Email IDs registered with the Company or its Registrar or Share Transfer Agent, regarding information of the Tax Deducted at Source on Dividend for the Financial Year 2022-23. | |
| |
| | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 13/07/23 13:08 | Company Update | |
| | Please find enclosed the Compliance Certificate received from Bigshare Private Limited, Registrar and Share Transfer Agent of Astec LifeSciences Limited for the Quarter Ended June 30, 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 04/07/23 19:06 | Company Update | |
| | Newspaper Publication of Notice of 29th AGM to be held through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"), E-Voting information and Book Closure. | |
| |
| | Intimation Of Book Closure For The Purpose Of Dividend | 03/07/23 22:11 | Corp. Action | |
| | Pursuant to Regulation 42 of the SEBI Listing Regulations, the Registrar of Members and Share Transfer Books of the Company will remained closed from Saturday, 22nd July , 2023 to Wednesday, 26th July, 2023. | |
| |
| | Astec Lifesciences Limited Has Informed The Exchange About Communication To Shareholders As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 About The 29Th (Twenty Ninth) Annual General Meeting ('AGM') Of The Company Scheduled To Be Held On Thursday, 27Th July, 2023 At 4.00 P.M. (IST) Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') | 03/07/23 22:07 | Company Update | |
| | Kindly find enclosed the Notice of 29th Annual General Meeting of Astec LifeSciences Limited. | |
| |
| | 29Th Annual General Meeting Scheduled To Be Held On Thursday, 27Th July, 2023 At 4.00 P.M. Through Video Conferencing / Other Audio Visual Means | 03/07/23 22:04 | AGM/EGM | |
| | In continuation of our letter dated 30th June, 2023 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the SEBI Listing Regulations for the Financial Year 2022-23, containing the Notice of the 29th (Twenty Ninth) Annual General Meeting ("AGM") of the Company scheduled to be held on Thursday , 27th July, 2023 at 4.00 p.m. (IST) through Video Conferencing / Other audio visual means. | |
| |
| | Reg. 34 (1) Annual Report. | 03/07/23 21:54 | | |
| | In continuation to our letter dated 30th June, 2023 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2022-23, containing inter alia, the Notice of the 29th .... | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 30/06/23 16:59 | Company Update | |
| | Pursuant to MCA General circular dated 5th May, 2020 and 13th January, 2021, read with Regulation 47, 30 and Schedule III of the SEBI Listing Regulations, please find enclosed the copies of newspaper advertisements published on Friday, 30th June, 2023 in Business Standard (in English Language) and Mumbai Lakshadeep (in Marathi Language), in respect of the information regarding the 29th AGM of the Company. | |
| |
| | Closure of Trading Window | 30/06/23 16:39 | Insider Trading / SAST | |
| | This is to inform you that as per the Company''s Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company will be closed with effect from Saturday, 1st July, 2023 till 48 (Forty-Eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter ending on 30th June, 2023 | |
| |
| | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | 20/06/23 17:02 | Company Update | |
| | This is to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company, on 20th June, 2023, has approved allotment of 441 Equity Shares of Face Value of Rs.10/- each, ranking pari passu with the existing Equity Shares, as fully paid up, upon exercise of Options granted under Employees Stock Option Plan, 2012 (ESOP 2012) by employees, at an Exercise Price of Rs.10/- (Rupees Ten Only) per Option.
The amount .... | |
| |
| | Announcement under Regulation 30 (LODR)-Credit Rating | 19/06/23 16:00 | Company Update | |
| | Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Credit Rating by India Ratings and Research Private Limited for Non-Convertible Debentures (NCDs) programme of Rs.50 Crore of Astec LifeSciences Limited. | |
| |
| | Reply On Significant Increase In The Volume Of Security Across Exchanges, In The Recent Past | 12/06/23 09:42 | Company Update | |
| | With reference to your Notice Ref. No.: L/SURV/ONL/PV/MG/ 2023-2024 / 126 dated 8th June, 2023, we wish to inform you that as a Listed Company, we are conscious of our responsibility to disseminate to the Stock Exchanges, information that could have an impact on the price of the Company's shares. Consistent with this approach, we have been promptly disseminating to the Stock Exchanges, events or information which are required to be disclosed pursuant .... | |
| |
| | Clarification sought from Astec Lifesciences Ltd | 08/06/23 12:39 | Company Update | |
| | The Exchange has sought clarification from Astec Lifesciences Ltd on June 8, 2023, with reference to Movement in Volume.
The reply is awaited. | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 01/06/23 13:44 | Company Update | |
| | This is to inform you under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') that Astec LifeSciences Limited will be participating an event 'Trinity India - 2023' (Annual Investor Conference) organized by Battlival & Karani Securities India Private Limited, scheduled to be held today, i.e., on Thursday, 1st June, 2023 at Mumbai. | |
| |
| | Compliances-Reg.24(A)-Annual Secretarial Compliance | 25/05/23 16:38 | Company Update | |
| | In compliance with Regulation 24A(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, the Annual Secretarial Compliance Report of Astec LifeSciences Limited ('the Company') for the Financial Year ended 31st March, 2023, issued by M/s. BNP & Associates, Company Secretaries. | |
| |
| | Revised Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023 | 10/05/23 20:06 | Company Update | |
| | Please find enclosed herewith, the revised disclosure of Related Party Transactions for the Half Year ended 31st March, 2023, pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021.
The above information is also being uploaded on the Company's website, viz., www.astecls.com.
| |
| |
| | Intimation Of Grant Of Options Under Astec Lifesciences Limited - Employees Stock Option Plan, 2012 | 09/05/23 20:42 | Company Update | |
| | Please find attached Intimation of Grant of Options under Astec LifeSciences Limited - Employees Stock Option Plan, 2012 | |
| |
| | Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | 02/05/23 21:42 | Company Update | |
| | Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, please find enclosed herewith, the disclosure of Related Party Transactions for the Half Year ended 31st March, 2023.
The above information is also being uploaded on the Company's website, viz., www.astecls.com. | |
| |
| | Announcement under Regulation 30 (LODR)-Press Release / Media Release | 02/05/23 20:06 | Company Update | |
| | The Board of Directors of Astec LifeSciences Limited ('the Company'), at its Meeting held on Tuesday, 2nd May, 2023, has approved the Audited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Financial Year ended 31st March, 2023. | |
| |
| | The Board Considered And Fixed The Date Of The 29Th (Twenty Ninth) Annual General Meeting | 02/05/23 19:11 | AGM/EGM | |
| | The 29th (Twenty Ninth) Annual General Meeting of the Shareholders of the Company will be held on Thursday, 27th July, 2023 at 4.00 p.m. | |
| |
| | APPOINTMENT OF MR. K. SURYANARAYAN AS THE 'CHIEF FINANCIAL OFFICER' OF THE COMPANY: | 02/05/23 19:02 | Company Update | |
| | The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee, has appointed Mr. K. Suryanarayan as the 'Chief Financial Officer' of the Company with effect from 3rd May, 2023. | |
| |
| | Resignation Of Mr. Madhur Gundecha As The 'Chief Financial Officer' Of The Company | 02/05/23 18:58 | Company Update | |
| | The Board has noted the resignation of Mr. Madhur Gundecha from the position of 'Chief Financial Officer' of the Company with effect from the close of business hours on 2nd May, 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | 02/05/23 18:55 | Company Update | |
| | This is to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Mr. Madhur Gundecha has resigned as the 'Chief Financial Officer' (CFO) of Astec LifeSciences Limited ('the Company') with effect from the close of business hours on 2nd May, 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Cessation | 02/05/23 18:50 | Company Update | |
| | This is to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Mr. Madhur Gundecha has resigned as the 'Chief Financial Officer' (CFO) of Astec LifeSciences Limited ('the Company') with effect from the close of business hours on 2nd May, 2023. | |
| |
| | Board Recommends Final Dividend. | 02/05/23 18:45 | Company Update | |
| | The Board of Directors has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty ) per Equity Share of Face
Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2023, subject to approval of the Shareholders at the ensuing 29th (Twenty Ninth) Annual General Meeting of
the Company. | |
| |
| | Announcement under Regulation 30 (LODR)-Dividend Updates | 02/05/23 18:26 | Corp Action | |
| | Please find attached outcome of the Board Meeting held today i.e. on 2nd May, 2023. | |
| |
| | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchange Board Of India(Listing Obligations And Disclosure Requirements) Regulations, 2015. | 02/05/23 18:17 | Corp. Action | |
| | Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 22nd July, 2023 to Wednesday, 26th July, 2023,(both days inclusive) for taking record of the Members of the Company for the purpose of the 29th (Twenty Ninth) Annual General Meeting and payment of Final Dividend. | |
| |
| | Corporate Action-Board approves Dividend | 02/05/23 18:00 | Corp. Action | |
| | The Board of Directors has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty ) per Equity Share of Face
Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2023, subject to approval of the Shareholders at the ensuing 29th (Twenty Ninth) Annual General Meeting of
the Company. | |
| |